Prediction market Myriad is on a roll, having revealed that it’s just surpassed $10M in USDC trading volume. That’s good going for the DeFi protocol, whose more than 500,000 users have placed a total of 5.4M predictions to date.Prediction market Myriad is on a roll, having revealed that it’s just surpassed $10M in USDC trading volume. That’s good going for the DeFi protocol, whose more than 500,000 users have placed a total of 5.4M predictions to date.

Myriad Charts More Milestones After Seeing Its Prediction Market Surpass $10M in Trading Volume

Prediction market Myriad is on a roll, having revealed that it’s just surpassed $10M in USDC trading volume. That’s good going for the DeFi protocol, whose more than 500,000 users have placed a total of 5.4M predictions to date. It’s further proof that prediction markets are fast becoming a cornerstone of DeFi, occupying a niche somewhere between trading and gaming.

Unlike conventional DeFi protocols such as DEXs, Myriad takes a fun approach to crypto markets, enabling users to venture on their future price movements and to earn a share of the rewards pool for making correct calls. But it’s not just crypto markets that Myriad users can participate in: its framework is equally suited to placing predictions on real-world events ranging from politics to sport. As a result, Myriad has attracted a diverse user base, all seeking to leverage their expertise within specific spheres to accurately cast predictions.

Gamifying the Future

Myriad has essentially gamified the future, be it that of crypto or of the global economy. Everyone has an opinion on the topics that are dearest to their heart, and Myriad enables them to put a price on that opinion and then see whether it aligns with the sentiment of other users. Popular markets that are live on Myriad right now include one venturing whether BTC will hit $125K or $105K next, with $175,000 of USDC having been ventured on the outcome.

Myriad users are also predicting whether President Trump will visit China in 2025; the start of the U.S. football season; and the price of a dozen eggs. These eclectic markets show the many ways in which Myriad can be used to gain an insight into global economic affairs, whose macro movements feed into the price of crypto assets and the cost of food. The clean yet colorful interface, which gives Myriad a web2 vibe more akin to that of a gaming platform, has helped it rapidly onboard hundreds of thousands of users, many of whom are now regulars.

The web app has been complemented by an optional browser extension that enables users to make predictions directly on social media and to earn points in the process. A leaderboard charts the most successful predictors in Myriad’s SZN 2, incentivizing them to compete for a share of the points on offer. In addition to participating in prediction markets, users can earn points through engaging with content and voting on governance decisions. This approach aligns with the InfoFi model of gamifying content creation and curation, forging highly engaged communities.

Myriad Goes Deeper

Having established a foothold in the onchain economy, including Abstract and Linea where its protocol is deployed, Myriad has plans to go further. According to CEO Loxley Fernandes, “We’re showing that trading ideas and forecasts is not only possible, it’s the next frontier for capital markets. Myriad is building the rails for prediction markets to evolve beyond a niche crypto product and become an entirely new segment of DeFi.”

That goal is set to be supported by further integration into EigenLayer and EigenCloud, while on the technical side, the platform will be enhanced by rolling out support for blended oracles coupled with a framework for ERC-PRED. This new asset class, engineered for prediction markets, should reinforce Myriad’s reputation as a rising star in the prediction economy, which has itself been predicted to achieve rapid growth over the next decade.

Disclaimer: This article is provided for informational purposes only. It is not offered or intended to be used as legal, tax, investment, financial, or other advice.

 

 

Market Opportunity
Moonveil Logo
Moonveil Price(MORE)
$0.00223
$0.00223$0.00223
-4.25%
USD
Moonveil (MORE) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Edges higher ahead of BoC-Fed policy outcome

Edges higher ahead of BoC-Fed policy outcome

The post Edges higher ahead of BoC-Fed policy outcome appeared on BitcoinEthereumNews.com. USD/CAD gains marginally to near 1.3760 ahead of monetary policy announcements by the Fed and the BoC. Both the Fed and the BoC are expected to lower interest rates. USD/CAD forms a Head and Shoulder chart pattern. The USD/CAD pair ticks up to near 1.3760 during the late European session on Wednesday. The Loonie pair gains marginally ahead of monetary policy outcomes by the Bank of Canada (BoC) and the Federal Reserve (Fed) during New York trading hours. Both the BoC and the Fed are expected to cut interest rates amid mounting labor market conditions in their respective economies. Inflationary pressures in the Canadian economy have cooled down, emerging as another reason behind the BoC’s dovish expectations. However, the Fed is expected to start the monetary-easing campaign despite the United States (US) inflation remaining higher. Investors will closely monitor press conferences from both Fed Chair Jerome Powell and BoC Governor Tiff Macklem to get cues about whether there will be more interest rate cuts in the remainder of the year. According to analysts from Barclays, the Fed’s latest median projections for interest rates are likely to call for three interest rate cuts by 2025. Ahead of the Fed’s monetary policy, the US Dollar Index (DXY), which tracks the Greenback’s value against six major currencies, holds onto Tuesday’s losses near 96.60. USD/CAD forms a Head and Shoulder chart pattern, which indicates a bearish reversal. The neckline of the above-mentioned chart pattern is plotted near 1.3715. The near-term trend of the pair remains bearish as it stays below the 20-day Exponential Moving Average (EMA), which trades around 1.3800. The 14-day Relative Strength Index (RSI) slides to near 40.00. A fresh bearish momentum would emerge if the RSI falls below that level. Going forward, the asset could slide towards the round level of…
Share
BitcoinEthereumNews2025/09/18 01:23